Successfully treated postoperative Candida parakrusei endophthalmitis.
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000867:Anterior Chamber / Q000601:surgery; D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000188:drug therapy*; D002387:Cataract Extraction; D048909:Diabetes Complications; D004322:Drainage; D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use; D009761:Nystatin / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011677:Punctures; D013431:Sulfates / Q000627:therapeutic use; D013997:Time Factors; D014792:Visual Acuity
D000935:Antifungal Agents; D011113:Polymyxins; D013431:Sulfates; D009761:Nystatin; D000666:Amphotericin B; D009355:Neomycin